Antibiotic utilization in hospitalized children under 2 years of age with influenza or respiratory syncytial virus infection - a comparative, retrospective analysis.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
17 Aug 2020
Historique:
received: 20 07 2020
accepted: 11 08 2020
entrez: 19 8 2020
pubmed: 19 8 2020
medline: 9 9 2020
Statut: epublish

Résumé

Infections due to Respiratory Syncytial Virus (RSV) and Influenza virus (FLU) are leading causes of hospitalization in young children. Yet, there is little data on factors associated with antibiotic use in these patients. We conducted a retrospective, single-center study of all patients below 2 years of age hospitalized between 2014 and 2018. We compared children with RSV infection to children with FLU infection analyzing clinical characteristics and factors contributing to an increased rate of antimicrobial utilization. RSV infection was diagnosed in 476/573 (83.1%), FLU in 95/573 (16.6%), and RSV-FLU-co-infection in 2/573 (0.3%) patients. Median age was lower for RSV compared to FLU (4 vs. 12 months; p < 0.0001). Children with RSV had longer hospitalization (5 vs. 4 days; p = 0.0023) and needed oxygen more frequently (314/476 vs. 23/95; p < 0.0001) than FLU patients. There was no significant difference in the overall antibiotic utilization between RSV and FLU patients (136/476 vs. 21/95; p = 0.2107). Logistic regression analyses revealed that septic appearance on admission (odds ratio [OR] 8.95, 95% confidence interval [CI] 1.5-54.1), acute otitis media (OR 4.5, 95% CI 2.1-9.4), a longer oxygen therapy (OR 1.40; 95% CI 1.13-1.74) and a higher C-reactive protein (CRP) (OR 1.7, 95% CI 1.5-2.0) were significantly associated with antibiotic use in both groups, but not age or pneumonia. In our cohort, the rate of antibiotic utilization was comparable between RSV and FLU patients, while for both groups distinct clinical presentation and a high CRP value were associated with higher antibiotic use.

Sections du résumé

BACKGROUND BACKGROUND
Infections due to Respiratory Syncytial Virus (RSV) and Influenza virus (FLU) are leading causes of hospitalization in young children. Yet, there is little data on factors associated with antibiotic use in these patients.
METHODS METHODS
We conducted a retrospective, single-center study of all patients below 2 years of age hospitalized between 2014 and 2018. We compared children with RSV infection to children with FLU infection analyzing clinical characteristics and factors contributing to an increased rate of antimicrobial utilization.
RESULTS RESULTS
RSV infection was diagnosed in 476/573 (83.1%), FLU in 95/573 (16.6%), and RSV-FLU-co-infection in 2/573 (0.3%) patients. Median age was lower for RSV compared to FLU (4 vs. 12 months; p < 0.0001). Children with RSV had longer hospitalization (5 vs. 4 days; p = 0.0023) and needed oxygen more frequently (314/476 vs. 23/95; p < 0.0001) than FLU patients. There was no significant difference in the overall antibiotic utilization between RSV and FLU patients (136/476 vs. 21/95; p = 0.2107). Logistic regression analyses revealed that septic appearance on admission (odds ratio [OR] 8.95, 95% confidence interval [CI] 1.5-54.1), acute otitis media (OR 4.5, 95% CI 2.1-9.4), a longer oxygen therapy (OR 1.40; 95% CI 1.13-1.74) and a higher C-reactive protein (CRP) (OR 1.7, 95% CI 1.5-2.0) were significantly associated with antibiotic use in both groups, but not age or pneumonia.
CONCLUSIONS CONCLUSIONS
In our cohort, the rate of antibiotic utilization was comparable between RSV and FLU patients, while for both groups distinct clinical presentation and a high CRP value were associated with higher antibiotic use.

Identifiants

pubmed: 32807104
doi: 10.1186/s12879-020-05336-5
pii: 10.1186/s12879-020-05336-5
pmc: PMC7430130
doi:

Substances chimiques

Anti-Bacterial Agents 0
C-Reactive Protein 9007-41-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

606

Références

J Pediatric Infect Dis Soc. 2020 Feb 28;9(1):51-55
pubmed: 30476135
Pediatrics. 2017 Oct;140(4):
pubmed: 28904072
JAMA. 2016 Aug 23-30;316(8):846-57
pubmed: 27552618
J Clin Med. 2017 Oct 07;6(10):
pubmed: 28991170
Lancet. 2019 Aug 31;394(10200):757-779
pubmed: 31257127
Pediatrics. 2003 Aug;112(2):363-7
pubmed: 12897288
J Clin Microbiol. 2018 Jun 25;56(7):
pubmed: 29695519
Pediatrics. 2014 Oct;134(4):e956-65
pubmed: 25225144
Lancet Glob Health. 2017 Oct;5(10):e984-e991
pubmed: 28911764
Clin Microbiol Infect. 2016 Jun;22(6):527-34
pubmed: 26916343
Eur J Clin Microbiol Infect Dis. 2019 Mar;38(3):505-514
pubmed: 30707378
Infection. 2019 Apr;47(2):201-207
pubmed: 30132249
BMJ. 2010 Apr 20;340:c1594
pubmed: 20406860
Influenza Other Respir Viruses. 2020 Jan;14(1):19-27
pubmed: 31625688
J Med Econ. 2020 Jul;23(7):673-682
pubmed: 32259465
Lancet Infect Dis. 2020 Jan;20(1):60-79
pubmed: 31678026
Clin Infect Dis. 2019 Sep 13;69(7):1243-1253
pubmed: 30689772
Thorax. 2006 Jul;61(7):611-5
pubmed: 16537670
JAMA. 2016 Aug 23-30;316(8):835-45
pubmed: 27552617
J Clin Virol. 2010 Aug;48(4):239-45
pubmed: 20646956
Lancet Infect Dis. 2017 Apr;17(4):431-440
pubmed: 28012942
PLoS One. 2015 Mar 18;10(3):e0120012
pubmed: 25785720
Pediatr Infect Dis J. 2018 Nov;37(11):1077-1081
pubmed: 29601448
Clin Infect Dis. 2016 May 15;62(10):e51-77
pubmed: 27080992
J Clin Virol. 2018 Jul;104:29-33
pubmed: 29704736
Pediatr Pulmonol. 2018 Sep;53(9):1225-1230
pubmed: 29943901
JAMA. 2016 May 3;315(17):1864-73
pubmed: 27139059
JAMA Pediatr. 2020 Mar 1;174(3):260-268
pubmed: 32011640
Eur J Clin Microbiol Infect Dis. 2019 Jan;38(1):171-176
pubmed: 30374685
Pediatr Infect Dis J. 2020 Jan;39(1):12-16
pubmed: 31651808
BMC Public Health. 2019 Aug 13;19(1):1090
pubmed: 31409319
J Pediatric Infect Dis Soc. 2020 Nov 10;9(5):587-595
pubmed: 31868913
Clin Infect Dis. 2019 Jun 18;69(1):24-33
pubmed: 30285232
Eur J Clin Microbiol Infect Dis. 2012 Nov;31(11):3173-82
pubmed: 22850740
Clin Microbiol Infect. 2019 Jul;25(7):898-903
pubmed: 30502486
PLoS One. 2014 May 02;9(5):e96189
pubmed: 24788944
Lancet. 2010 Mar 6;375(9717):834-45
pubmed: 20132979
J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):241-248
pubmed: 29267871
Lancet Infect Dis. 2019 Apr;19(4):382-391
pubmed: 30827808
Eur J Clin Microbiol Infect Dis. 2018 Jul;37(7):1361-1371
pubmed: 29700762
Sci Rep. 2019 Aug 13;9(1):11780
pubmed: 31409879
J Clin Epidemiol. 2019 Aug;112:20-27
pubmed: 30930247
BMJ. 2011 Jun 08;342:d3082
pubmed: 21653621
J Infect Dis. 2020 Mar 28;221(8):1244-1255
pubmed: 30982895
Pediatr Infect Dis J. 2019 Sep;38(9):e233
pubmed: 31408060

Auteurs

Cihan Papan (C)

Pediatric Infectious Diseases, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. cihan.papan@uks.eu.
Center for Infectious Diseases, Institute of Medical Microbiology and Hygiene, Saarland University, Kirrberger Strasse, Building 43, 66421, Homburg, Germany. cihan.papan@uks.eu.

Meike Willersinn (M)

Pediatric Infectious Diseases, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Christel Weiß (C)

Institute of Medical Statistics and Biomathematics, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Michael Karremann (M)

Pediatric Infectious Diseases, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Horst Schroten (H)

Pediatric Infectious Diseases, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Tobias Tenenbaum (T)

Pediatric Infectious Diseases, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH